Jacquemet et al., 1990 - Google Patents

Effect of prolactin infusion on lactation, glucose kinetics, and pancreatic hormones in lactating goats

Jacquemet et al., 1990

View PDF
Document ID
2491647501597654343
Author
Jacquemet N
Prigge E
Publication year
Publication venue
Journal of dairy science

External Links

Snippet

To determine lactational and glucogenic responses to increased prolactin concentrations, five lactating dairy goats were used in a crossover design. Prolactin at. 85 mg/h or placebo was infused on each of 8 consecutive d via jugular catheter for 14 h initiated 30 min after the …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH] (Somatotropin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication Publication Date Title
Peel et al. Effect of exogenous growth hormone in early and late lactation on lactational performance of dairy cows
Rigout et al. Duodenal glucose increases glucose fluxes and lactose synthesis in grass silage-fed dairy cows
Bauman et al. Responses of high-producing dairy cows to long-term treatment with pituitary somatotropin and recombinant somatotropin
Plaut et al. Effect of exogenous prolactin administration on lactational performance of dairy cows
McDowell et al. Effects of exogenous growth hormone on milk production and nutrient uptake by muscle and mammary tissues of dairy cows in mid-lactation
Eppard et al. Effect of 188-day treatment with somatotropin on health and reproductive performance of lactating dairy cows
Peel et al. Lactational response to exogenous growth hormone and abomasal infusion of a glucose-sodium caseinate mixture in high-yielding dairy cows
Whitworth et al. Transfer of milk prolactin to the plasma of neonatal rats by intestinal absorption
Eisemann et al. Nitrogen and protein metabolism and metabolites in plasma and urine of beef steers treated with somatotropin
McDowell et al. Local intra-arterial infusion of growth hormone into the mammary glands of sheep and goats: effects on milk yield and composition, plasma hormones and metabolites
Fronk et al. Comparison of different patterns of exogenous growth hormone administration on milk production in Holstein cows
US5292721A (en) Use of growth hormone to enhance porcine fetal energy and sow lactation performance
US10828277B2 (en) Antioxidant complex for reducing number of somatic cell in livestock animal, and preparation method and application thereof
Beermann et al. Exogenous human growth hormone-releasing factor and ovine somatotropin improve growth performance and composition of gain in lambs
Amaral et al. Metabolism of propionate, glucose, and carbon dioxide as affected by exogenous glucose in dairy cows at energy equilibrium
Chalupa et al. Responses of dairy cows supplemented with somatotropin during weeks 5 through 43 of lactation
Hixon et al. Effects of creep feeding and monensin on reproductive performance and lactation of beef heifers
Powell et al. A potential strategy for decreasing milk production in the ewe at weaning using a growth hormone release blocker
Sandles et al. Responses of lactating ewes to exogenous growth hormone: short-and long-term effects on productivity and tissue utilization of key metabolites
Jacquemet et al. Effect of prolactin infusion on lactation, glucose kinetics, and pancreatic hormones in lactating goats
McDowell et al. Effects of pituitary-derived bovine growth hormone on production parameters and biokinetics of key metabolites in lactating dairy cows at peak and mid-lactation
Yuen Prolactin in human milk: the influence of nursing and the duration of postpartum lactation
McCann et al. Insulin response to glucose in estrous and diestrous obese and lean heifers
Jacquemet et al. Effect of increased postmilking prolactin concentrations on lactation, plasma metabolites, and pancreatic hormones in lactating goats
EP0652767B1 (en) Treatment of human lactation failure